Want to see IN:FDC full AI Analyst Report?

FDC Ltd. (FDC) Price & Analysis

0 Followers

FDC Stock Chart & Stats

₹411.30

₹4.15(1.00%)

At close: Jul 27 4:00 PM EDT

₹411.30

₹4.15(1.00%)

Day’s Range― - ―

52-Week Range₹314.75 - ₹528.30

Previous CloseN/A

Volume60.67K

Average Volume (3M)13.01K

Market Cap

₹55.62B

Enterprise Value₹47.22K

Total Cash (Recent Filing)₹5.23B

Total Debt (Recent Filing)₹0.00

Price to Earnings (P/E)19.1

Beta0.69

Next Earnings

Oct 27, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield1.45%

Share Statistics

EPS (TTM)17.98

Shares Outstanding162,810,090

10 Day Avg. Volume7,139

30 Day Avg. Volume13,007

Financial Highlights & Ratios

PEG Ratio3.51

Price to Book (P/B)2.10

Price to Sales (P/S)2.41

P/FCF Ratio83.90

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Conservative Balance SheetVery low leverage limits refinancing risk and preserves financial flexibility. A growing equity base provides additional resilience for investment, supplier commitments, and industry volatility without relying heavily on external financing.

Steady Revenue And Earnings GrowthSustained revenue expansion and positive earnings growth indicate resilient demand for FDC’s specialty and generic medicines. Continued operating scale can support durable profitability if the company maintains product relevance and market access.

Solid ProfitabilityStrong absolute earnings provide an internal funding base for operations and selected growth initiatives. This reduces dependence on new borrowing and supports the company’s ability to absorb cost pressures while continuing to serve established markets.

Bears Say

Margin PressureA sustained decline in margins could limit earnings growth even when revenue expands. The pattern may reflect rising costs, product-mix changes, or pricing pressure, making future profitability less durable than the company’s revenue trajectory.

Volatile Free Cash FlowUneven conversion of profits into free cash flow reduces visibility over internally generated funding. Working-capital movements or investment timing may continue to create variability, complicating reinvestment, dividend, and liquidity planning.

Moderating Returns On EquityLower returns on equity suggest earnings are not expanding as quickly as the capital base. If this persists, it may indicate weaker capital efficiency and reduce the benefit shareholders receive from retaining and reinvesting profits.

FDC Ltd. News

FDC Gets USFDA ANDA Nod for Fluconazole Tablets

FDC Ltd. ( ($IN:FDC) ) has provided an update. FDC Ltd. has received approval from the U.S. Food...

8M ago

FDC

FDC Limited Confirms Compliance with SEBI Regulations for Q3 2025

FDC Ltd. ( ($IN:FDC) ) has shared an update. FDC Limited has submitted a certificate to the stock...

11M ago

FDC

FDC FAQ

What was FDC Ltd.’s price range in the past 12 months?

FDC Ltd. lowest stock price was ₹314.75 and its highest was ₹528.30 in the past 12 months.

What is FDC Ltd.’s market cap?

FDC Ltd.’s market cap is ₹55.62B.

When is FDC Ltd.’s upcoming earnings report date?

FDC Ltd.’s upcoming earnings report date is Oct 27, 2026 which is in 51 days.

How were FDC Ltd.’s earnings last quarter?

FDC Ltd. released its earnings results on Aug 05, 2026. The company reported ₹8.138 earnings per share for the quarter.

Is FDC Ltd. overvalued?

According to Wall Street analysts FDC Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does FDC Ltd. pay dividends?

FDC Ltd. pays a Notavailable dividend of ₹5 which represents an annual dividend yield of 1.45%. See more information on FDC Ltd. dividends here

What is FDC Ltd.’s EPS estimate?

FDC Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does FDC Ltd. have?

FDC Ltd. has 162,810,090 shares outstanding.

What happened to FDC Ltd.’s price movement after its last earnings report?

FDC Ltd. reported an EPS of ₹8.138 in its last earnings report. Following the earnings report the stock price went down -3.846%.

Which hedge fund is a major shareholder of FDC Ltd.?

Currently, no hedge funds are holding shares in IN:FDC

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

FDC Ltd.

FDC Limited, together with its subsidiaries, manufactures and trades in pharmaceutical products in India, the United States, and internationally. The company offers pharmaceutical formulations for various therapeutic segments, including anti-infectives, gastrointestinal, ophthalmology, vitamins, minerals, dietary supplements, cardiovascular and anti-diabetic therapies, respiratory care, gynaecology, dermatology, and analgesics in the form of tablets, capsules, oral liquids, ophthalmic drops, topical preparations, and paediatric-friendly solutions. It also provides functional food, such as flavoured ORS powders, ready-to-drink electrolyte beverages, vitamin-enriched supplements, antioxidant blends and protein-fortified drinks; and various active pharmaceutical ingredients. The company sells its products under the Zifi, Zefu, Zocon, Amodep-AT, Zathrin, Vitcofol, Ziglim, Ziglim-M,Mycoderm, Zoxan, Cotaryl, Pyrimon DF, Zipod, Electral, and Enerzal brands. It also exports its products to approximately 50 countries. FDC Limited was founded in 1936 and is based in Mumbai, India.